Kings Ark Crest

The Kings Ark Mingle™

Decentralized • AI Powered • Universal

Estimated Trade: 0

Active Users: 0

Date: --

Time: --:--:--

Crest

The Kings Ark Mingle™

Decentralized • AI Powered • Universal

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanc

Welcome aboard The Kings Ark™ — where this living chronicle records our rise, our code, and our covenant with creation.

💠

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanc

Komentari · 21 Pogledi

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, removes diseased stem cells without radiation, enab

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, removes diseased stem cells without radiation, enabling nearly complete donor cell replacement. The approach also widens donor eligibility and could soon be applied to other bone marrow failure diseases.

Read Original

The Media Hub: The Kings Ark™
Komentari